Aimed Bio Inc. (KOSDAQ:0009K0)
48,750
-100 (-0.20%)
At close: Apr 29, 2026
Aimed Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 106,408 | 4,488 | 1,463 | 2,872 |
Short-Term Investments | 64,420 | 31,030 | 16,618 | 3,146 |
Cash & Short-Term Investments | 170,828 | 35,519 | 18,081 | 6,018 |
Cash Growth | 380.96% | 96.45% | 200.42% | - |
Accounts Receivable | 3,300 | - | - | 45.46 |
Other Receivables | 2,871 | 459.85 | 659.65 | 388.9 |
Receivables | 6,171 | 459.85 | 659.65 | 434.36 |
Prepaid Expenses | - | 103.96 | - | - |
Other Current Assets | 1,523 | 144.95 | 68.76 | 130.83 |
Total Current Assets | 178,523 | 36,227 | 18,809 | 6,584 |
Property, Plant & Equipment | 2,104 | 1,469 | 2,353 | 2,157 |
Long-Term Investments | 1,835 | 6,537 | 220.88 | 1,305 |
Other Intangible Assets | 1,619 | 1,742 | 334.61 | 325.41 |
Long-Term Deferred Tax Assets | 13,683 | - | - | - |
Other Long-Term Assets | 1,205 | 1,166 | 714.93 | 558.24 |
Total Assets | 198,969 | 47,141 | 22,432 | 10,929 |
Accrued Expenses | 910.67 | 181.93 | 197.61 | 63.69 |
Current Portion of Leases | 639.58 | 425.57 | 525.67 | 490.95 |
Current Unearned Revenue | 340.91 | 795.46 | 1,295 | 140.79 |
Other Current Liabilities | 3,788 | 725.35 | 2,404 | 227.48 |
Total Current Liabilities | 5,679 | 2,128 | 4,423 | 922.9 |
Long-Term Leases | 525.13 | - | 375.01 | 521.93 |
Other Long-Term Liabilities | 192.23 | 195.6 | 32.43 | 28.98 |
Total Liabilities | 6,397 | 2,324 | 4,830 | 1,474 |
Common Stock | 32,078 | 17,735 | 17,735 | 16,716 |
Additional Paid-In Capital | 179,636 | 8,979 | 8,979 | 4,830 |
Retained Earnings | -21,413 | -26,436 | -23,132 | -14,109 |
Comprehensive Income & Other | 2,268 | 3,082 | 3,112 | 2,007 |
Total Common Equity | 192,569 | 3,360 | 6,694 | 9,443 |
Minority Interest | 3.15 | 7.5 | 15.66 | 12.29 |
Shareholders' Equity | 192,572 | 44,817 | 17,602 | 9,456 |
Total Liabilities & Equity | 198,969 | 47,141 | 22,432 | 10,929 |
Total Debt | 1,165 | 425.57 | 900.68 | 1,013 |
Net Cash (Debt) | 169,663 | 35,093 | 17,180 | 5,006 |
Net Cash Growth | 383.47% | 104.27% | 243.21% | - |
Net Cash Per Share | 3411.80 | 987.82 | 503.02 | 149.73 |
Filing Date Shares Outstanding | 60.02 | 35.47 | 35.47 | 33.43 |
Total Common Shares Outstanding | 60.02 | 35.47 | 35.47 | 33.43 |
Working Capital | 172,843 | 34,099 | 14,386 | 5,661 |
Book Value Per Share | 3208.15 | 94.73 | 188.73 | 282.47 |
Tangible Book Value | 190,950 | 1,619 | 6,360 | 9,118 |
Tangible Book Value Per Share | 3181.18 | 45.63 | 179.29 | 272.73 |
Machinery | 2,712 | 2,469 | 2,329 | 1,895 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.